WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Health services deal value holds steady in 2026 with higher bar for investment: PwC

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report | The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a midyear outlook report from PwC.

Raccontata dafiercehealthcare.comfiercepharma.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
fiercehealthcare.com2 g fa

KFF: Insurer participation in the ACA marketplaces declined from 2025 to 2026

ACA marketplace insurer participation declined to 9.0 per state in 2026 from 9.6 in 2025, with 165 counties limited to single insurer and six carriers planning 2027 exits. The decline ends post-COVID tax-credit-driven growth; consolidation signals profitability pressures and raises affordability risks.

Leggi questa versione → originale
fiercepharma.com11 h fa

'Biopharma ecosystem is back to full health,' fueled by M&A: PwC

With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since 2020, analysts from PwC have declared that the “biopharma ecosystem is ba | With pharma and…

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 15 giugno 2026·fiercehealthcare.com

    InStride Health lands $30M series C to expand pediatric mental health services

    InStride Health, a provider of specialty mental healthcare to children, teens and young adults, landed $30 million in series C funding to fuel its growth as it expands to new…

  2. lunedì 15 giugno 2026·fiercehealthcare.com

    KFF: Insurer participation in the ACA marketplaces declined from 2025 to 2026

    The number of insurers offering plans on the Affordable Care Act's marketplaces declined between 2025 and 2026, with more payers poised for an exit ahead of the 2027 plan year,…

  3. martedì 16 giugno 2026·fiercehealthcare.com

    US telehealth utilization climbs 10.1% in Q1, led by mental health visits: Fair Health

    Telehealth utilization increased 10.1% across the U.S. | The top five diagnostic categories were mental health, acute respiratory diseases and infections, overweight and obesity,…

  4. martedì 16 giugno 2026·fiercehealthcare.com

    CMS tightens oversight of accreditation facilities, limits fee-based consulting

    The Centers for Medicare and Medicaid Services (CMS) has locked in tighter oversight of accrediting organizations’ alignment with Medicare standards, as well as new protections…

  5. martedì 16 giugno 2026·fiercehealthcare.com

    MedPAC offers a look at enrollment hiccups for Medicare beneficiaries

    Beneficiaries face a series of complex decisions in enrolling in Medicare coverage, and a key federal panel outlines some of the pain points. | Beneficiaries face a series of…

  6. mercoledì 17 giugno 2026·fiercepharma.com

    'Biopharma ecosystem is back to full health,' fueled by M&A: PwC

    With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since 2020, analysts from PwC have declared that the…

  7. mercoledì 17 giugno 2026·fiercehealthcare.com

    Health services deal value holds steady in 2026 with higher bar for investment: PwC

    The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers and dealmakers "reprice risk," according to a…